ProMIS Neurosciences Valeur d'entreprise
Quel est le Valeur d'entreprise de ProMIS Neurosciences?
Le Valeur d'entreprise de ProMIS Neurosciences, Inc. est $32.72M
Quelle est la définition de Valeur d'entreprise?
La valeur d'entreprise est une mesure de la valeur marchande totale d'une entreprise. Il correspond à la capitalisation boursière avec la dette, les intérêts minoritaires et les actions privilégiées moins la trésorerie et les équivalents de trésorerie totaux.
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Valeur d'entreprise des entreprises dans Health Care secteur sur TSX par rapport à ProMIS Neurosciences
Que fait ProMIS Neurosciences?
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
Entreprises avec valeur d'entreprise similaire à ProMIS Neurosciences
- IT Link SA a Valeur d'entreprise de $32.61M
- Chanjet Information Technology a Valeur d'entreprise de $32.63M
- Ritamix Global a Valeur d'entreprise de $32.63M
- Avalon GloboCare a Valeur d'entreprise de $32.66M
- Perimeter Medical Imaging AI a Valeur d'entreprise de $32.70M
- One Experience SA a Valeur d'entreprise de $32.72M
- ProMIS Neurosciences a Valeur d'entreprise de $32.72M
- Aro Granite Industries a Valeur d'entreprise de $32.73M
- HML plc a Valeur d'entreprise de $32.73M
- GeNeuro SA (Switzerland) a Valeur d'entreprise de $32.74M
- Compagnie Industrielle et Financiere d'Entreprises SA a Valeur d'entreprise de $32.75M
- Imricor Medical Systems a Valeur d'entreprise de $32.77M
- Imricor Medical Systems a Valeur d'entreprise de $32.77M